The new expert opinion paper by the ESC working on the optimal strategy for antiplateletet therapy in patients undergoing CABG
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Coronary Disease - Surgery
Expert position paper on the management of antiplatelet therapy in patients undergoing coronary artery bypass graft surgery
April 26, 2014
April 24, 2014
This article compares clinical adverse events after percutaneous intervention with drug‐eluting stents (DESs) and coronary artery bypass grafting (CABG) in patients with ESRD. Early mortality is lower with DESs compared with coronary artery bypass in patients with ESRD. Rate of reintervention is significantly higher in the DES cohort.
Long-term survival is lower in off pump versus on pump CABG patients reports a study of 5203 patients published in JACC.
April 24, 2014
Long-term survival following coronary artery bypass grafting: off-pump versus on-pump strategies JACC - Journal of the American College of Cardiology, 04/18/2014 Evidence Based Medicine Clinical Article
April 16, 2014
Ischaemic heart disease is a major risk factor for heart failure. However, long–term benefit of percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) in those patients has not been well elucidated.
Five-Year Outcomes in Patients with Left Main Disease Treated with Either Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting in the SYNTAX Trial.
April 13, 2014
This manuscript reports on the 5-year outcomes in the 705 patients with left main (LM) lesions enrolled in the randomized arm of the SYNTAX trial. Follow-up data to 5 years were available in 96.9% of patients who underwent PCI and 92.5% of patients randomized to CABG.
April 9, 2014
Bauters C, et al. – There are limited data on the prognosis of patients with stable coronary artery disease (CAD) in modern clinical practice. The mortality rate of patients with stable CAD in modern clinical practice is similar to that of the general population and is mostly due to noncardiovascular causes.
April 2, 2014
Quality metrics based on administrative databases are sometimes unreliable. This study examined data from nearly 245,000 Medicare patients undergoing CABG to determine the reliability of 30-day readmission rates and whether that metric is an appropriate indicator of hospital quality.
March 17, 2014
Takagi H, et al. – A 12–year–ago landmark meta–analysis of bilateral versus single internal thoracic artery (bilateral ITA [BITA] versus single ITA [SITA]) coronary artery bypass grafting for long–term survival included 7 observational studies (only 3 of which reported adjusted hazard ratios [HRs]) enrolling approximately 16,000 patients.
February 6, 2014
Because the optimal management of CAD is unclear for many patients, the authors developed a decision support model for CABG and PCI with bare metal or drug eluting stents. Overall survival rates were similar for the different interventions.